COSMOS HEALTH NEW DL-01 (V67A) - Total Liabilities
Based on the latest financial reports, COSMOS HEALTH NEW DL-01 (V67A) has total liabilities worth €47.05 Million EUR (≈ $55.01 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore COSMOS HEALTH NEW DL-01 (V67A) cash flow conversion to assess how effectively this company generates cash.
COSMOS HEALTH NEW DL-01 - Total Liabilities Trend (2021–2025)
This chart illustrates how COSMOS HEALTH NEW DL-01's total liabilities have evolved over time, based on quarterly financial data. Check COSMOS HEALTH NEW DL-01 liquid asset ratio to evaluate the company's liquid asset resilience ratio.
COSMOS HEALTH NEW DL-01 Competitors by Total Liabilities
The table below lists competitors of COSMOS HEALTH NEW DL-01 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Thai Capital Corporation Public Company Limited
BK:TCC
|
Thailand | ฿351.12 Million |
|
West International AB
ST:WPAY
|
Sweden | Skr40.13 Million |
|
Megalestari Epack Sentosaraya Pt
JK:EPAC
|
Indonesia | Rp184.47 Billion |
|
Speedvalue Ltd
TA:SPDV
|
Israel | ILA54.97 Million |
|
ITM Power
LSE:ITM
|
UK | GBX129.61 Million |
|
Daehan Flour Mills Co Ltd
KO:001130
|
Korea | ₩525.62 Billion |
|
Euromedis Groupe SA
PA:ALEMG
|
France | €23.04 Million |
|
MDJM Ltd
NASDAQ:UOKA
|
USA | $379.58K |
Liability Composition Analysis (2021–2025)
This chart breaks down COSMOS HEALTH NEW DL-01's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see COSMOS HEALTH NEW DL-01 (V67A) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.55 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.72 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how COSMOS HEALTH NEW DL-01's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for COSMOS HEALTH NEW DL-01 (2021–2025)
The table below shows the annual total liabilities of COSMOS HEALTH NEW DL-01 from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €47.05 Million ≈ $55.01 Million |
+58.01% |
| 2024-12-31 | €29.78 Million ≈ $34.81 Million |
-0.64% |
| 2023-12-31 | €29.97 Million ≈ $35.04 Million |
+5.60% |
| 2022-12-31 | €28.38 Million ≈ $33.18 Million |
-37.00% |
| 2021-12-31 | €45.05 Million ≈ $52.67 Million |
-- |
About COSMOS HEALTH NEW DL-01
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It als… Read more